Clinton Carroll
Pediatric Hematology-Oncology · Nashville, TNNPI 1215100011
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Sobi, Inc accounts for 72.2% of it on its own, with 35 other manufacturers making up the rest. 2025 is the largest year on record at $6,240, more than ten times the $183 reported in 2019.
Across 101 payments — averaging $80.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sobi, Inc$6K
- Jazz Pharmaceuticals Inc.$268
- Novo Nordisk$198
- Pharming Healthcare, Inc.$196
- Mesoblast, Inc.$142
- UCB, Inc.$135
- plus $1K from 30 others
What the payments were for
- Consulting fees$4,60856%
- Travel & lodging$6969%
- Food & beverage$2,77934%
- Education$811%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sobi, Inc | 12 | $5,896 |
| Jazz Pharmaceuticals Inc. | 5 | $268 |
| Novo Nordisk | 10 | $198 |
| Pharming Healthcare, Inc. | 8 | $196 |
| Mesoblast, Inc. | 3 | $142 |
| UCB, Inc. | 4 | $135 |
| Amgen | 7 | $133 |
| Vertex | 1 | $124 |
| Springworks Therapeutics, Inc. | 5 | $123 |
| Pfizer | 4 | $90 |
| Azurity Pharmaceuticals, Inc. | 4 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $79 |
| Novartis | 3 | $58 |
| Seagen Inc. | 4 | $57 |
| Day One Biopharmaceuticals | 2 | $48 |
| Agios Pharmaceuticals, Inc. | 2 | $46 |
| Medexus Pharma, Inc. | 2 | $40 |
| Corium, LLC | 1 | $33 |
| Aucta Pharmaceuticals, Inc. | 2 | $32 |
| Bayer | 1 | $30 |
| Immedica Pharma US, Inc. | 1 | $29 |
| Syndax Pharmaceuticals, Inc. | 1 | $26 |
| Krystal Biotech Inc | 1 | $25 |
| RARE Disease Therapeutics, Inc. | 1 | $24 |
| X4 Pharmaceuticals, Inc. | 1 | $24 |
| Y-mabs Therapeutics, Inc. | 1 | $24 |
| Servier Pharmaceuticals LLC | 2 | $23 |
| Tris Pharma Inc | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| AbbVie | 1 | $20 |
| Mirum Pharmaceuticals, Inc. | 1 | $18 |
| Insulet Corporation | 1 | $18 |
| Duchesnay USA Incorporated | 1 | $17 |
| Emmaus Medical, Inc. | 1 | $17 |
| Albireo Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,164 in reported general payments places this provider in the 70th percentile of 113 pediatric hematology-oncology providers in Tennessee.
See all pediatric hematology-oncology providers in Tennessee →
Other pediatric hematology-oncology in Nashville
- Jennifer DommNashville$359K
- Haydar FrangoulNashville$356K
- Carrie KitkoNashville$51K
- Michael DebaunNashville$39K
- Alexandra BorstNashville$27K
- James ConnellyNashville$21K
- Scott BorinsteinNashville$21K
- Heather McDanielNashville$8K
- Elizabeth YangNashville$7K
- Meghann McManusNashville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.